Underrepresentation of Women in Late-Breaking Cardiovascular Clinical Trials.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of women's health"
DOI: 10.1089/jwh.2022.0536
Abstract: Background: Cardiovascular disease is the leading cause of mortality for women and men. Prior studies have demonstrated the underrepresentation of women in published clinical trials, but no study to date has assessed inclusion of women… read more here.
Keywords: underrepresentation women; clinical trials; cardiology; late breaking ... See more keywords
Highlights of Transcatheter Cardiovascular Therapeutics 2019.
Sign Up to like & getrecommendations! Published in 2019 at "Circulation"
DOI: 10.1161/circulationaha.119.044689
Abstract: December 3, 2019 1943 Transcatheter Cardiovascular Therapeutics (TCT) is an annual scientific congress sponsored and organized by the Cardiovascular Research Foundation in New York, and is dedicated to the optimal management of patients with coronary,… read more here.
Keywords: medicine; ticagrelor; cardiovascular therapeutics; transcatheter cardiovascular ... See more keywords
Late Breaking Abstract - Study of natural autoantibodies in rheumatoid arthritis patients with pulmonary involvement
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.oa2894
Abstract: Aim: The object of study was to determine autoantibodies (Abs) in patients with rheumatoid arthritis (RA) and their correlation with clinical manifestation. Materials and Methods: 20 adults aged 60,8 ± 6,2 years old with RA,… read more here.
Keywords: abstract study; study natural; breaking abstract; rheumatoid arthritis ... See more keywords
Late Breaking Abstract - Obesity hypoventilation syndrome treated with non-invasive ventilation: can we switch to CPAP?
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.oa4427
Abstract: OHS is one of the most frequent indications for long-term NIV worldwide. Nevertheless, CPAP therapy has proven to be a suitable therapy for a significant percentage of these patients. The device election has relevant implications,… read more here.
Keywords: stable ohs; ohs patients; cpap; late breaking ... See more keywords
Late Breaking Abstract - Pulmonary hypertension modifies cardiac genes myh7 and col1a1 nonreversible by training
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa2803
Abstract: Pulmonary hypertension (PH) is a serious disease that leads to cor pulmonale and right heart failure. It is still unknown the effects of preventive training in early stages of PH regarding the genes in right… read more here.
Keywords: pulmonary hypertension; myh7 col1a1; training; late breaking ... See more keywords
Late Breaking Abstract - Polysomnography and clinical characteristics of patients presenting to single sleep referral clinic-study over 6 years
Sign Up to like & getrecommendations! Published in 2017 at "European Respiratory Journal"
DOI: 10.1183/1393003.congress-2017.pa2810
Abstract: Introduction: Sleep disordered breathing (SDB) disorders are major cause of morbidity and mortality. We studied clinical characteristics and PSG correlation of SDB. Aim Objective and Methods: 1028 patients analysed who presented to our referral sleep… read more here.
Keywords: study; single sleep; clinic; clinical characteristics ... See more keywords
Late Breaking Abstract - NORdic Database for aSThmA Research (NORDSTAR) : Swedish and Finnish patients
Sign Up to like & getrecommendations! Published in 2018 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2018.pa1143
Abstract: Background: A cross-border research collaboration was recently initiated across the Nordic countries. These countries maintain population-based registers containing a variety of patient-level healt ... read more here.
Keywords: nordic database; research; database asthma; breaking abstract ... See more keywords
Late Breaking Abstract - Multidisciplinary medical team in severe COVID-19 treatment
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.333
Abstract: Background: The pandemic of COVID-19 is emerging Concomitant comorbidities are major cause of death after SARS-Cov2 infection Multidisciplinary groups involved intervention should be a great potential for better outcomes in severe COVID-19 Method: A multidisciplinary… read more here.
Keywords: team; treatment; medical team; multidisciplinary medical ... See more keywords
Late Breaking Abstract - IMPACT OF CONFINEMENT ON ALS PATIENTS DUE TO THE SARS-CoV-2 PANDEMIC
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.390
Abstract: Introduction: The covid-19 pandemic has forced the confinement of one third of the world's population, which could have a special impact on ALS patients Objective:To analyze the impact that the quarantine decreed by the Spanish… read more here.
Keywords: therapy; impact; confinement; als patients ... See more keywords
Late Breaking Abstract - Thromboembolic complications in COVID-19 patients admitted to two large East London hospitals
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.4039
Abstract: Introduction: COVID-19 may predispose to both venous and arterial thromboembolism, with reports of increased incidence of thromboembolic complications noted in the literature (Lodigiani et al, Thrombosis research, 2020, 191:9-14) We aimed to determine the incidence… read more here.
Keywords: east london; thromboembolic complications; abstract thromboembolic; complications covid ... See more keywords
Late Breaking Abstract - LUSTER-1 and -2: randomised controlled trials of fevipiprant in severe asthma
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.congress-2020.4614
Abstract: Introduction: Fevipiprant, an oral, non-steroidal, highly selective, reversible antagonist of the PGD2 receptor 2, improved lung function and sputum eosinophil counts in asthma patients in Phase II clinical trials. Aim: To determine whether fevipiprant reduces… read more here.
Keywords: severe asthma; trials fevipiprant; placebo; controlled trials ... See more keywords